Skip to content
Home/Companies/Biotech/Enveda Biosciences

Enveda Biosciences

Biotech·United States·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Enveda Biosciences?

Enveda Biosciences is an American Biotech company, currently owned by Kinnevik since 2023.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Kinnevik
Investor
Kinnevik
Kinnevik · 1991 · Growth

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Kinnevik

Other portfolio companies in the same fund.

Anterior
Active
HealthTechUS· 2025
Breathe Battery Technologies
Active
ClimateTechUK· 2025
Encube
Active
IndustrialsSweden· 2025
Kernel
Kernel
Active
SaaSUK· 2025
Nory
Nory
Active
SaaSIreland· 2025
Oviva
Oviva
Active
HealthTechSwitzerland· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Enveda Biosciences?

Enveda Biosciences is currently owned by Kinnevik, through Kinnevik, since 2023.

When did Kinnevik acquire Enveda Biosciences?

Kinnevik acquired Enveda Biosciences in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue